Home » News » Awards & Advancement » Ampio names chief business officer

Ampio names chief business officer

Monday, August 22, 2011

Ampio Pharmaceuticals has named Deborah Knobelman, Ph.D., chief business officer reporting directly to Ampio CEO, Don Wingerter.

Knobelman most recently served at Pfizer for three years as director of strategy and analytics for Pfizer’s primary care product portfolio. Knobelman previously worked on Wall Street as an equity research analyst covering the specialty pharmaceuticals sector for several investment banks.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!